Description: Los Alamos National Laboratory is offering exclusive or non-exclusive licenses to patented technology intended to improve the manufacture and reliability of high-temperature heat-pipe reactors. The platform covers porous-wick fabrication and controlled filling, sealing, and inspection of heat-pipe arrays, with process automation and quality checks to support more consistent production. LANL may also loan full-scale prototype fill-system hardware, and the notice states that it is not a call for external development services.
Federal · DC, US
Adjacent opportunities open for bidding right now.
Posted
Jun 4, 2026
Dec 3, 2026
High-temperature heat pipe reactors by improving the way critical wick structures are manufactured and how heat pipe arrays are filled, sealed, and checked for quality.
Posted
Jun 19, 2026
Dec 19, 2026
The heat pipe reactor fire mitigation and suppression system from laboratory, transforms the heat pipes inside an alkali metal-cooled nuclear reactor from passive thermal conduits into active, sensor-driven fire defense components, giving designers of advanced small and microreactors a layered, automated safeguard against one of the most challenging hazards in their systems. By combining an inert gas buffer, a phase change material jacket, automated suppressant injection at multiple points and optional neutron-absorber dispersion into the reactor core, the system delivers redundant protection that responds within milliseconds of detecting fire-like conditions. This system enables advanced reactor developers to meet stringent safety expectations for remote, unattended and space-constrained deployments without redesigning the core architecture around bulky external suppression equipment.
Posted
Jun 4, 2026
Dec 3, 2026
A novel platform for improving the safety and effectiveness of therapeutic gas-based treatments by enabling controlled, localized delivery at the site of disease. By addressing longstanding challenges associated with systemic exposure and dosing precision, the platform enhances the clinical viability of gas therapies across high-value markets such as oncology, cardiovascular care, and regenerative medicine. In addition, the inclusion of a complementary predictive modeling capability supports treatment optimization and development efficiency, reducing technical risk and accelerating translation. Together, these capabilities position the technology as a differentiated and scalable solution that can unlock new commercial opportunities in areas where gas-based therapeutics have shown promise but faced delivery limitations.
Posted
Jun 15, 2026
Dec 15, 2026
The bacterial lipid nanodiscs platform developed by llaboratory provides a new way to study entire bacterial membranes in a controlled, nanoscale format derived directly from native lipid extracts. Researchers gain access to membrane components that typically remain difficult to isolate, stabilize or analyze, enabling more accurate evaluation of immunogenic lipids and membrane associated targets. The platform offers a safer alternative to handling live high risk pathogens while preserving the biological context that drives meaningful insights for vaccine design and antimicrobial discovery such as therapeutic antibodies to conserved lipids on bacterial membranes.
Original attachments and procurement documents tied to this bid.
Federal RFP files are for Starbridge customers only.
You can request RFP files from all other buyer types for free on this site.
Decision makers connected to this RFP from Department of Energy.
